Henry Schein focuses on long-term strategy, shares in a defensive health peer group
28.06.2026 - 12:03:28 | ad-hoc-news.de
By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-28, 12:02.
Henry Schein (US42548G1040) remains a mid-cap fixture in U.S. health care distribution. The stock trades on the NASDAQ alongside sector peers McKesson and Cardinal Health, anchoring it in the defensive health care segment favored by many institutional investors.
Long-term positioning in health care
Henry Schein reports annual revenue above 10 billion dollars, according to recent company filings, with a diversified mix of dental, medical and animal health products and services. The business targets small and mid-sized practitioners, a segment that tends to show robust, recurring demand in both expansionary and weaker economic phases.
The company’s strategic focus on practice-based customers differentiates it from broader hospital-focused wholesalers like McKesson or AmerisourceBergen, while still keeping it within the same defensive sector bucket that many investors monitor for stability and cash generation.
Sector peers and defensive profile
McKesson, Cardinal Health and AmerisourceBergen all trade on the NYSE and together form a large-cap health care distribution peer group that has historically shown relatively muted volatility compared with more cyclical industries. Henry Schein, with its NASDAQ listing and mid-cap profile, sits slightly below these giants in scale but participates in similar structural trends.
These peers provide a benchmark for investors assessing Henry Schein’s valuation metrics such as price-to-earnings ratios, profit margins and free cash flow generation, numbers that are regularly compiled by analyst platforms and sector research houses.
Background and price data on Henry Schein
Further company filings, analyst consensus data and intraday price information on Henry Schein can be accessed via the ad-hoc-news topic page and the firm’s investor relations site.
The products behind the stock
Henry Schein’s core business revolves around supplying dental practices with clinical consumables, equipment and digital solutions, including items such as dental chairs, X-ray systems and practice management software. The company also distributes vaccines and medical supplies to physician offices, aligning its revenue streams closely with everyday health care delivery.
Where the stock trades today
Henry Schein shares (US42548G1040) trade primarily on the NASDAQ in U.S. dollars. As of the latest available quotation, the stock price reflects the company’s positioning within the health care distribution peer group rather than short-term trading impulses.
Henry Schein at a glance
- Company: Henry Schein, Inc.
- ISIN: US42548G1040
- WKN: 897961
- Ticker: HSIC
- Trading venue: NASDAQ
- Price (as of 2026-06-28, 12:02): value USD
- Market cap: value USD (as of 2026-06-28)
- Sector / industry: Health Care Distribution / Medical Supplies
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This text is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any other form of financial guidance.
